PALISADE BIO, INC. Operating Cash Flow
PALISADE BIO, INC. (PALI) reported Operating Cash Flow of -$11.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- PALISADE BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$7.60M.
- PALISADE BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.89M.
- PALISADE BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.14M.
- PALISADE BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.55M.
- PALISADE BIO, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$10.85M.
- PALISADE BIO, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$12.19M.
- PALISADE BIO, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$11.13M.
- PALISADE BIO, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$13.36M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$7.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$11.49M 10-Q · filed 2026-08-10 | -$14.64M derived: sum of 3 quarters · filed 2026-08-10 | -$18.19M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$3.89M 10-Q · filed 2026-05-12 | -$7.03M derived: sum of 2 quarters · filed 2026-05-12 | -$10.59M derived: sum of 3 quarters · filed 2026-05-12 | -$12.40M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | -$6.70M derived: sum of 2 quarters · filed 2026-03-20 | -$8.51M derived: sum of 3 quarters · filed 2026-08-10 | -$10.85M 10-K · filed 2026-03-20 | ||||
| 2025-09-30 | -$3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$5.37M derived: sum of 2 quarters · filed 2026-08-10 | -$7.70M 10-Q · filed 2025-11-10 | -$10.08M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$4.15M 10-Q · filed 2026-08-10 | -$6.53M derived: sum of 3 quarters · filed 2026-08-10 | -$9.66M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | -$2.33M 10-Q · filed 2026-05-12 | -$4.71M derived: sum of 2 quarters · filed 2026-05-12 | -$7.85M derived: sum of 3 quarters · filed 2026-05-12 | -$11.35M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | -$5.51M derived: sum of 2 quarters · filed 2026-03-20 | -$9.01M derived: sum of 3 quarters · filed 2026-03-20 | -$12.19M 10-K · filed 2026-03-20 | ||||
| 2024-09-30 | -$3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$6.63M derived: sum of 2 quarters · filed 2025-11-10 | -$9.81M 10-Q · filed 2025-11-10 | -$12.56M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$6.68M 10-Q · filed 2025-08-11 | -$9.43M derived: sum of 3 quarters · filed 2025-08-11 | -$12.09M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | -$3.18M 10-Q · filed 2025-05-12 | -$5.93M derived: sum of 2 quarters · filed 2025-05-12 | -$8.59M derived: sum of 3 quarters · filed 2025-05-12 | -$10.79M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | -$2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$5.41M derived: sum of 2 quarters · filed 2025-03-24 | -$7.61M derived: sum of 3 quarters · filed 2025-03-24 | -$11.13M 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | -$2.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$4.86M derived: sum of 2 quarters · filed 2024-11-12 | -$8.39M 10-Q · filed 2024-11-12 | -$11.69M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$5.72M 10-Q · filed 2024-08-12 | -$9.03M derived: sum of 3 quarters · filed 2024-08-12 | -$12.07M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | -$3.53M 10-Q · filed 2024-05-13 | -$6.83M derived: sum of 2 quarters · filed 2024-05-13 | -$9.87M derived: sum of 3 quarters · filed 2024-05-13 | -$13.12M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | -$3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$6.35M derived: sum of 2 quarters · filed 2024-03-26 | -$9.60M derived: sum of 3 quarters · filed 2024-03-26 | -$13.36M 10-K · filed 2024-03-26 | ||||
| 2022-09-30 | -$3.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$6.29M derived: sum of 2 quarters · filed 2023-11-09 | -$10.05M 10-Q · filed 2023-11-09 | -$13.11M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$3.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$7.01M 10-Q · filed 2023-08-10 | -$10.07M derived: sum of 3 quarters · filed 2023-08-10 | -$12.81M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$3.76M 10-Q · filed 2023-05-11 | -$6.82M derived: sum of 2 quarters · filed 2023-05-11 | -$9.56M derived: sum of 3 quarters · filed 2023-05-11 | -$17.29M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$5.80M derived: sum of 2 quarters · filed 2023-03-22 | -$13.52M derived: sum of 3 quarters · filed 2023-03-22 | -$14.77M 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | -$2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$10.47M derived: sum of 2 quarters · filed 2022-11-14 | -$11.72M 10-Q · filed 2022-11-14 | -$13.27M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$7.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$8.97M 10-Q · filed 2022-08-15 | -$10.52M derived: sum of 3 quarters · filed 2022-08-15 | -$11.39M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$1.25M 10-Q · filed 2022-05-13 | -$3.94M 10-Q · filed 2021-05-14 | -$2.80M derived: sum of 2 quarters · filed 2022-05-13 | -$3.67M derived: sum of 3 quarters · filed 2022-05-13 | -$4.34M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | -$1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$2.42M derived: sum of 2 quarters · filed 2022-03-17 | -$3.09M derived: sum of 3 quarters · filed 2022-03-17 | -$4.77M 10-K · filed 2022-03-17 | -$9.03M 10-K · filed 2021-03-22 | |||
| 2020-09-30 | -$869.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.54M derived: sum of 2 quarters · filed 2021-11-12 | -$3.22M 10-Q · filed 2021-11-12 | -$6.83M 10-Q · filed 2020-11-10 | -$5.27M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | -$673.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-23 | -$2.35M 10-Q · filed 2021-08-23 | -$3.75M 10-Q · filed 2020-08-13 | -$4.40M derived: sum of 3 quarters · filed 2021-08-23 | -$6.30M derived: sum of 4 quarters · filed 2021-08-23 | |||
| 2020-03-31 | -$1.68M 10-Q · filed 2021-05-14 | -$3.73M derived: sum of 2 quarters · filed 2021-05-14 | -$5.62M derived: sum of 3 quarters · filed 2021-05-14 | -$7.27M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | -$2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | -$3.95M derived: sum of 2 quarters · filed 2021-03-22 | -$5.59M derived: sum of 3 quarters · filed 2021-03-22 | -$7.26M 10-K · filed 2021-03-22 | ||||
| 2019-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$3.54M derived: sum of 2 quarters · filed 2020-11-10 | -$5.21M 10-Q · filed 2020-11-10 | -$6.86M derived: sum of 4 quarters · filed 2020-11-10 | ||||
| 2019-06-30 | -$1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$3.31M 10-Q · filed 2020-08-13 | -$4.97M derived: sum of 3 quarters · filed 2020-08-13 | -$6.63M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | -$1.67M 10-Q · filed 2020-05-15 | -$3.32M derived: sum of 2 quarters · filed 2020-05-15 | -$4.99M derived: sum of 3 quarters · filed 2020-05-15 | -$7.51M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | -$1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$3.32M derived: sum of 2 quarters · filed 2020-03-27 | -$5.85M derived: sum of 3 quarters · filed 2020-03-27 | -$7.69M 10-K · filed 2020-03-27 | ||||
| 2018-09-30 | -$1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$4.19M derived: sum of 2 quarters · filed 2019-11-14 | -$6.03M 10-Q · filed 2019-11-14 | -$8.32M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | -$2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$4.37M 10-Q · filed 2019-08-14 | -$6.66M derived: sum of 3 quarters · filed 2019-08-14 | -$9.98M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | -$1.85M 10-Q · filed 2019-05-14 | -$4.13M derived: sum of 2 quarters · filed 2019-05-14 | -$7.46M derived: sum of 3 quarters · filed 2019-05-14 | -$10.83M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$5.61M derived: sum of 2 quarters · filed 2019-03-22 | -$8.98M derived: sum of 3 quarters · filed 2019-03-22 | -$13.42M 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | -$3.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$6.69M derived: sum of 2 quarters · filed 2018-11-14 | -$11.13M 10-Q · filed 2018-11-14 | -$15.21M derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | -$3.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$7.81M 10-Q · filed 2018-08-13 | -$11.89M derived: sum of 3 quarters · filed 2018-08-13 | |||||
| 2017-03-31 | -$4.44M 10-Q · filed 2018-05-15 | -$8.52M derived: sum of 2 quarters · filed 2018-05-15 | ||||||
| 2016-12-31 | -$4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$15.62M 10-K · filed 2018-04-02 | ||||||
| 2016-09-30 | -$11.54M 10-Q · filed 2017-11-08 | |||||||
| 2013-09-30 | -$2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$5.60M derived: sum of 2 quarters · filed 2013-11-12 | -$8.12M 10-Q · filed 2013-11-12 | -$10.63M derived: sum of 4 quarters · filed 2013-11-12 | ||||
| 2013-06-30 | -$3.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$5.87M 10-Q · filed 2013-08-08 | -$8.39M derived: sum of 3 quarters · filed 2013-08-08 | -$9.81M derived: sum of 4 quarters · filed 2013-11-12 | ||||
| 2013-03-31 | -$2.51M 10-Q · filed 2013-05-10 | -$5.03M derived: sum of 2 quarters · filed 2013-05-10 | -$6.45M derived: sum of 3 quarters · filed 2013-11-12 | -$8.89M derived: sum of 4 quarters · filed 2013-11-12 | ||||
| 2012-12-31 | -$2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$3.94M derived: sum of 2 quarters · filed 2013-11-12 | -$6.38M derived: sum of 3 quarters · filed 2013-11-12 | -$8.48M 10-K · filed 2013-03-15 | ||||
| 2012-09-30 | -$1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$3.86M derived: sum of 2 quarters · filed 2013-11-12 | -$5.96M 10-Q · filed 2013-11-12 | -$7.74M derived: sum of 4 quarters · filed 2013-11-12 | ||||
| 2012-06-30 | -$2.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$4.54M 10-Q · filed 2013-08-08 | -$6.32M derived: sum of 3 quarters · filed 2013-08-08 | -$8.14M derived: sum of 4 quarters · filed 2013-08-08 | ||||
| 2012-03-31 | -$2.10M 10-Q · filed 2013-05-10 | -$3.88M derived: sum of 2 quarters · filed 2013-05-10 | -$5.70M derived: sum of 3 quarters · filed 2013-05-10 | -$7.91M derived: sum of 4 quarters · filed 2013-05-10 | ||||
| 2011-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$3.60M derived: sum of 2 quarters · filed 2013-03-15 | -$5.81M derived: sum of 3 quarters · filed 2013-03-15 | -$8.10M 10-K · filed 2013-03-15 | ||||
| 2011-09-30 | -$1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$4.03M derived: sum of 2 quarters · filed 2012-11-09 | -$6.31M 10-Q · filed 2012-11-09 | -$9.06M derived: sum of 4 quarters · filed 2012-11-09 | ||||
| 2011-06-30 | -$2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$4.50M 10-Q · filed 2012-08-09 | -$7.25M derived: sum of 3 quarters · filed 2012-08-09 | -$9.60M derived: sum of 4 quarters · filed 2012-08-09 | ||||
| 2011-03-31 | -$2.29M 10-Q · filed 2012-05-09 | -$5.04M derived: sum of 2 quarters · filed 2012-05-09 | -$7.39M derived: sum of 3 quarters · filed 2012-05-09 | |||||
| 2010-12-31 | -$2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$5.10M derived: sum of 2 quarters · filed 2012-03-30 | -$9.98M 10-K · filed 2012-03-30 | |||||
| 2010-09-30 | -$2.35M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | -$7.23M 10-Q · filed 2011-11-09 | ||||||
| 2010-06-30 | -$4.88M 10-Q/A · filed 2011-09-23 | |||||||
| 2009-12-31 | -$5.14M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |